Nasacort (Triamcinolone Acetonide)

Triamcinolone acetonide, the active ingredient in Nasacort, is a corticosteroid presented as a nasal spray for intranasal use. It is employed to treat allergic rhinitis and related nasal inflammation in adults and children.

GNH USA supplies Nasacort as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasacort is a nasal corticosteroid that reduces inflammation in the upper airway. - Allergic rhinitis: alleviates nasal itching, sneezing and congestion caused by seasonal or perennial allergens. - Seasonal allergic rhinitis: provides symptom relief during pollen seasons by decreasing mucosal swelling. - Nasal congestion due to inflammation: improves airflow by reducing inflammatory secretions in the nasal passages.

Adverse reactions may occur with intranasal corticosteroids.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Sneezing shortly after administration. - Mild headache. - Epistaxis (nosebleed) in some users.

Serious or Rare Side Effects: - Nasal septal perforation. - Secondary infection of the nasal passages. - Elevated intra‑ocular pressure or glaucoma. - Systemic corticosteroid effects such as adrenal suppression (rare with recommended use).

Before using Nasacort, consider the following safety points. - Pregnancy: consult a healthcare professional; safety data are limited. - Breastfeeding: discuss potential risks with a physician. - Pre‑existing infections: avoid use if active nasal or sinus infections are present. - Recent nasal surgery or trauma: defer use until healing is complete. - Concomitant ocular disease: monitor intra‑ocular pressure if glaucoma is known. - Store at room temperature: keep in the original container, protect from moisture and direct sunlight.

Nasacort may interact with other medications that affect corticosteroid metabolism or immune function.

Major Interactions (Avoid): - Systemic corticosteroids: may increase risk of systemic effects. - CYP3A4 inhibitors (e.g., ketoconazole): could raise local drug exposure.

Moderate Interactions (Monitor Closely): - Antihistamines: may enhance nasal dryness. - Antiviral nasal sprays: potential for additive irritation. - Immunosuppressants: monitor for increased infection risk.